| Authors: |
Denize T; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hou Y; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Pignon JC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Walton E; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., West DJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Freeman GJ; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Braun DA; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Wu CJ; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Gupta S; Bristol-Myers Squibb, Princeton, New Jersey., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC., McDermott D; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Choueiri TK; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Shukla SA; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
